ISO 9001:2015 & ICMR Guidelines Compliant
+91-7744005984 WhatsApp Triage contact@stemcelltherapyinindia.com
EN | عربية | ES | FR
Institutional Profile

Overview & Clinical Philosophy

Dedicated to patient safety, ethical regenerative protocols, and seamless clinical coordination for international patients seeking cellular treatments in India.

MD

Medically Reviewed & Fact-Checked

Medical Advisory Board & Dr. Hanna Matthews, MD

All patient guidance complies with the Indian Council of Medical Research (ICMR) and National Guidelines for Stem Cell Research.

Audited: March 2026 Editorial Policy →

Pioneering Regenerative Healthcare in India

Over the past two decades, India has emerged as a premier global destination for advanced medical care. Combining world-class tertiary hospitals accredited by the Joint Commission International (JCI) and the National Accreditation Board for Hospitals & Healthcare Providers (NABH) with cutting-edge biotechnology cleanrooms, India provides advanced cellular therapy solutions at an accessible price point.

Stem Cell Therapy Center India functions as a dedicated international clinical coordination network. We partner exclusively with accredited academic institutions and superspecialty hospitals in New Delhi NCR, Mumbai, Bangalore, and Chennai to deliver evidence-based autologous and certified allogeneic cellular therapies.

Our Core Clinical Commitments

✓
cGMP Laboratory Standards All cellular products are processed in ISO Class 5 / Class 10,000 cleanroom environments.
✓
Strict Ethical Compliance All investigational protocols are conducted under Institutional Ethics Committee (IEC) oversight.
✓
Multidisciplinary Evaluation Every case is reviewed by senior hematologists, neurologists, and regenerative physicians.
✓
Global Concierge Care End-to-end medical visa letters, airport transfers, translator support, and long-term tele-follow-up.

Evidence-Based Treatment Scope

We strictly delineate established, standard-of-care cellular treatments from investigational applications:

  • Standard Indications: Hematopoietic Stem Cell Transplantation (HSCT) for leukemia, lymphoma, myeloma, aplastic anemia, thalassemia, and sickle cell disorders.
  • Investigational Indications: Mesenchymal Stem Cell (MSC) administration for neurodegenerative diseases (ALS, Parkinson's, MS), orthopedic joint cartilage degeneration, and chronic kidney dysfunction under clinical research protocols.
Meet Our Medical Team → View Mission & Vision → Tour Our Facilities → Browse Conditions →
Direct Inquiry

Consult Our Medical Board

Speak with our clinical team regarding treatments and accredited partner hospitals.